Abstract
We analyze risk factors correlated with the initial transmission growth rate of the recent COVID-19 pandemic in different countries. The number of cases follows in its early stages an almost exponential expansion; we chose as a starting point in each country the first day with 30 cases and we used 12 days, capturing thus the early exponential growth. We looked then for linear correlations of the exponents with other variables, for a sample of 126 countries. We find a positive correlation, faster spread of COVID-19 , with high confidence level with the following variables, with respective p-value: low Temperature (4×10 -7), high ratio of old vs. working-age people (3×10 -6), life expectancy (8×10 -6), number of international tourists (1×10 -5), earlier epidemic starting date (2×10 -5), high level of physical contact in greeting habits (6×10 -5), lung cancer prevalence (6×10 -5), obesity in males (1×10 -4), share of population in urban areas (2×10 -4), cancer prevalence (3×10 -4), alcohol consumption (0.0019), daily smoking prevalence (0.0036), UV index (0.004, smaller sample, 73 countries), low Vitamin D serum levels (0.002-0.006, smaller sample, 50 countries). There is highly significant correlation also with blood type: positive correlation with types RH- (2×10 -5) and A+ (2×10 -3), negative correlation with B+ (2×10 -4). We also find positive correlation with moderate confidence level (p-value of 0.02-0.03) with: CO2/SO emissions, type-1 diabetes in children, low vaccination coverage for Tuberculosis (BCG). Several of the above variables are correlated with each other and so they are likely to have common interpretations. Other variables are found to have a counterintuitive negative correlation, which may be explained due their strong negative correlation with life expectancy: slower spread of COVID-19 is correlated with high death-rate due to pollution, prevalence of anemia and hepatitis B, high blood pressure in females. We also analyzed the possible existence of a bias: countries with low GDP-per capita, typically located in warm regions, might have less intense testing and we discuss correlation with the above variables.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
FAPESP proc. 2017/06508-7, partecipation in FAPESP tematico 2017/05685-2 and CNPQ bolsa de produtividade 301432/2017-1
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data are publicly available
